Stock 300294 CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Highlights China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Equities

300294

CNE100001FF1

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
34.42 CNY -0.15% Intraday chart for China Resources Boya Bio-pharmaceutical Group Co.,Ltd +4.08% +2.20%
04-23 China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023
CI
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend
CI
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
MT
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.
CI
CR Boya Bio-Pharmaceutical's January-September Profit Increases
MT
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million
CI
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..
CI
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.
CI
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits
MT
China Resources Boya's H1 Attributable Profit Jumps 16.9%
MT
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises
MT
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023
CI
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit
MT
China Resources Boya Bio-Pharmaceutical Group Co., Ltd. Proposes Dividend for the Year 2022
CI
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300294 Stock
  4. News China Resources Boya Bio-pharmaceutical Group Co.,Ltd
  5. Highlights